Abbonarsi

Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries : Results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART) - 28/08/11

Doi : 10.1016/S0002-8703(03)00080-2 
Laura Mauri, MD, MS b, c, f, Mark Reisman, MD a, Maurice Buchbinder, MD e, Jeffrey J Popma, MD c, Samin K Sharma, MD d, Donald E Cutlip, MD f, g, Kalon K.L Ho, MD, MSc f, g, Ross Prpic, MD f, Peter J Zimetbaum, MD f, g, Richard E Kuntz, MD, MSc b, c, f,
a Swedish Hospital, Seattle, Wash,, USA 
b Clinical Biometrics, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass, USA 
c Cardiovascular Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass, USA 
d Mt Sinai Hospital, New York, NY, USA 
e Scripps Memorial Hospital, La Jolla, Calif, USA 
f Harvard Clinical Research Institute, Boston, Mass, USA 
g Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass, USA 

*Reprint requests: Richard E. Kuntz, MD, MSc, Division of Clinical Biometrics, Brigham and Women’s Hospital, 75 Francis St, Boston MA 02115, USA.

Abstract

Background

The optimum treatment of obstructive coronary disease in small (<3.0 mm diameter) arteries remains unknown. Rotational atherectomy is an approved treatment that might reduce the vascular injury during percutaneous coronary intervention compared with angioplasty. We report on a multicenter, randomized, blinded end point trial comparing rotational atherectomy with balloon angioplasty in the prevention of restenosis of obstructed small coronary arteries.

Methods

A total of 446 patients with myocardial ischemia associated with an angiographic stenosis in a native coronary artery 2 to 3 mm in diameter and ≤20 mm in length without severe calcification were randomly assigned to receive rotational atherectomy (n = 227) or balloon angioplasty (n = 219). The primary end point was target vessel failure at 12 months (defined as the composite of death, Q-wave myocardial infarction, and clinically driven repeat revascularization of the target vessel).

Results

The mean reference vessel diameter was 2.46 ± 0.40 mm, the mean lesion length was 9.97 ± 5.59 mm, and the prevalence of diabetes mellitus was 32%. Acute procedural success (91.6% for rotational atherectomy, 94.1% for balloon angioplasty, P = .36) and target vessel failure at 12 months were not significantly different (30.5% vs 31.2%, P = .98). At 8 months, there were no significant differences in minimum lumen diameter (1.28 ± 0.63 mm vs 1.19 ± 0.54 mm, P = .26), percent diameter stenosis (28% ± 12% vs 29% ± 15%, P = .59), binary restenosis rate (50.5% vs 50.5%, P = 1.0), or late loss index (0.57 vs 0.62, P = .7). No Q-wave myocardial infarctions occurred in either arm of the study, and non–Q-wave myocardial infarctions (defined as creatine kinase level >2 times normal with an elevated creatine kinase-myocardial band isoenzyme level) occurred in 2.2% and 1.4% of the patients in the rotational atherectomy and balloon angioplasty groups, respectively (P = .72).

Conclusion

Rotational atherectomy was found to be safe in the treatment of obstructed small arteries, but lower rates of target vessel failure were not achieved compared with balloon angioplasty. Because the acute gain and loss index ratios of the 2 treatments were similar, there was no evident beneficial antirestenosis mechanism seen for rotational atherectomy.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Supported by Boston Scientific Interventional Technologies, Natick, Mass.


© 2003  Mosby, Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 145 - N° 5

P. 847-854 - Maggio 2003 Ritorno al numero
Articolo precedente Articolo precedente
  • Comparison of acute changes in left ventricular volume, systolic and diastolic functions, and intraventricular synchronicity after biventricular and right ventricular pacing for heart failure
  • Cheuk-Man Yu, Hong Lin, Wing-Hong Fung, Qing Zhang, Shun-Ling Kong, John E Sanderson
| Articolo seguente Articolo seguente
  • Outcomes of primary coronary angioplasty and angioplasty after initial thrombolysis in the treatment of 374 consecutive patients with acute myocardial infarction
  • Lech Polo?ski, Mariusz Gåsior, Jaros?aw Wasilewski, Krzysztof Wilczek, Andrzej Wn?k, E.l?bieta Adamowicz-Czoch, MD, Jacek Sikora, Andrzej Lekston, Tadeusz Z?bik, Marek Gierlotka, Rafa? Wojnar, Janusz Szkodzi?ski, Marek Kondys, B.o?ena Szygu?a-Jurkiewicz, Robert Wo?k, Marian Zembala

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.